Going Concern (Details) - USD ($)		1 Months Ended			2 Months Ended	3 Months Ended		12 Months Ended
Going Concern (Details) - USD ($)	May 06, 2016	Jul. 24, 2017	Feb. 28, 2017	Mar. 31, 2016	Sep. 30, 2015	Dec. 31, 2017	Dec. 31, 2016	Sep. 30, 2017	Sep. 30, 2016
Going Concern (Textual)
Accumulated deficit						$ (15,776,598)		$ (15,395,384)
Net loss for the period					$ (315,602)	(381,214)	$ (210,337)	(4,071,983)	$ (11,007,799)
Working capital deficiency						$ 1,756,915		1,393,063
Common stock newly issued, value					$ 51,958			$ 5,850,000	$ 3,250,000
Collaborative Arrangement [Member]
Going Concern (Textual)
Milestone payments to BioLite in cash	$ 2,600,000
Common stock newly issued, value	$ 900,000	$ 3,000,000
Issuance of common shares, shares	562,500
Share price	$ 1.60		$ 2.0
Percentage of payments under collaborative agreement		0.50%				15.00%		0.035%
Accounts payable						$ 15,000,000
Collaborative Arrangement One [Member]
Going Concern (Textual)
Milestone payments to BioLite in cash			$ 650,000
Common stock newly issued, value			$ 5,850,000
Issuance of common shares, shares			2,925,000
Share price			$ 2.0
Percentage of payments under collaborative agreement				0.065%
Accounts payable				$ 6,500,000